Movement Alert｜Zai Lab Rises 5.15% in Regular Trading, Medical Insurance Policy Boost Drives Innovative Drug Sector Higher

Market Focus07-10

On July 10, Zai Lab rose 5.15% in regular trading, trading at HKD 16.13 per share, with turnover of HKD 158 million.

On the news front, the National Healthcare Security Administration recently announced that newly negotiated drugs added to the medical insurance catalog have been deployed across 310,000 designated medical institutions nationwide, benefiting over 12 million patient visits. The commercial insurance innovative drug catalog now covers more than 1,486 institutions. Notably, Zai Lab products previously appeared on the preliminary review list for medical insurance catalog inclusion.

The continued optimization of the payment environment on the policy side, combined with broader sector strength, triggered a notable rally across biotechnology stocks. Within the sector, 3SBio rose 6.12%, Innovent Biologics gained 4.46%, and Akeso advanced 3.96%, reflecting a clear sector-wide linkage effect. Broker research has highlighted that the medical insurance negotiation mechanism and commercial insurance catalog are jointly supporting genuine innovation, with innovative drug companies expected to benefit from expanded access and incremental commercial opportunities.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1184340897?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-10 13:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1184340897","market":"hk","top_or_hot":-1,"title":"Movement Alert｜Zai Lab Rises 5.15% in Regular Trading, Medical Insurance Policy Boost Drives Innovative Drug Sector Higher","media":"Market Focus","content":"<p><p>On July 10, Zai Lab rose 5.15% in regular trading, trading at HKD 16.13 per share, with turnover of HKD 158 million.</p><p>On the news front, the National Healthcare Security Administration recently announced that newly negotiated drugs added to the medical insurance catalog have been deployed across 310,000 designated medical institutions nationwide, benefiting over 12 million patient visits. The commercial insurance innovative drug catalog now covers more than 1,486 institutions. Notably, Zai Lab products previously appeared on the preliminary review list for medical insurance catalog inclusion.</p><p>The continued optimization of the payment environment on the policy side, combined with broader sector strength, triggered a notable rally across biotechnology stocks. Within the sector, 3SBio rose 6.12%, Innovent Biologics gained 4.46%, and Akeso advanced 3.96%, reflecting a clear sector-wide linkage effect. Broker research has highlighted that the medical insurance negotiation mechanism and commercial insurance catalog are jointly supporting genuine innovation, with innovative drug companies expected to benefit from expanded access and incremental commercial opportunities.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Zai Lab Rises 5.15% in Regular Trading, Medical Insurance Policy Boost Drives Innovative Drug Sector Higher</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Zai Lab Rises 5.15% in Regular Trading, Medical Insurance Policy Boost Drives Innovative Drug Sector Higher\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-10 13:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 10, Zai Lab rose 5.15% in regular trading, trading at HKD 16.13 per share, with turnover of HKD 158 million.</p><p>On the news front, the National Healthcare Security Administration recently announced that newly negotiated drugs added to the medical insurance catalog have been deployed across 310,000 designated medical institutions nationwide, benefiting over 12 million patient visits. The commercial insurance innovative drug catalog now covers more than 1,486 institutions. Notably, Zai Lab products previously appeared on the preliminary review list for medical insurance catalog inclusion.</p><p>The continued optimization of the payment environment on the policy side, combined with broader sector strength, triggered a notable rally across biotechnology stocks. Within the sector, 3SBio rose 6.12%, Innovent Biologics gained 4.46%, and Akeso advanced 3.96%, reflecting a clear sector-wide linkage effect. Broker research has highlighted that the medical insurance negotiation mechanism and commercial insurance catalog are jointly supporting genuine innovation, with innovative drug companies expected to benefit from expanded access and incremental commercial opportunities.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09688","symbol_name":"再鼎医药","start_time":0,"source_url":"","article_id":"1184340897","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1184340897","pubTimestamp":1783660955,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 10, Zai Lab rose 5.15% in regular trading, trading at HKD 16.13 per share, with turnover of HKD 158 million.On the news front, the National Healthcare Security Administration recently...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09688":"再鼎医药"},"translate_title":"异动提醒|再鼎医药常规交易涨5.15%，医保政策提振带动创新药板块走高","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09688":1},"content_text":"On July 10, Zai Lab rose 5.15% in regular trading, trading at HKD 16.13 per share, with turnover of HKD 158 million.On the news front, the National Healthcare Security Administration recently announced that newly negotiated drugs added to the medical insurance catalog have been deployed across 310,000 designated medical institutions nationwide, benefiting over 12 million patient visits. The commercial insurance innovative drug catalog now covers more than 1,486 institutions. Notably, Zai Lab products previously appeared on the preliminary review list for medical insurance catalog inclusion.The continued optimization of the payment environment on the policy side, combined with broader sector strength, triggered a notable rally across biotechnology stocks. Within the sector, 3SBio rose 6.12%, Innovent Biologics gained 4.46%, and Akeso advanced 3.96%, reflecting a clear sector-wide linkage effect. Broker research has highlighted that the medical insurance negotiation mechanism and commercial insurance catalog are jointly supporting genuine innovation, with innovative drug companies expected to benefit from expanded access and incremental commercial opportunities.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1184340897","isCrawlerRequest":true}